August 2021

New Cancer Treatment Options for People in Gippsland

People being treated for cancer in Gippsland can now participate in clinical trials at Monash Health, opening up new therapeutic options that have not previously been available.

Supported by funding from the Victorian Government, a new telehealth clinic has been introduced to match patients living in Gippsland with oncology clinical trials hosted at Monash Health.

Continue reading »

SMICS and NEMICS Pancreatic Resectability Project Update

The pancreatic resectability project is an opportunity to shift patient outcomes by consistent and standardised radiological synoptic reporting, in this way providing valuable inputs into MDM discussion for patient surgery and therapy recommendations. The pilot conducted at Austin and Alfred Health concludes 30 September, 2021.

Continue reading »

‘ROSIE’ the Robot Giving McGrath Breast Care Nurses Access to Vital Training from Anywhere in Australia

Patients with metastatic, or incurable, breast cancer will benefit from an innovative new training program being piloted by the McGrath Foundation, Monash Health, Monash University and Southern Melbourne Integrated Cancer Services (SMICS).

Continue reading »

Biocurate and Monash University Accelerate Research into Targeted Treatments for Triple Negative Breast Cancer

The first award under BioCurate’s new “Proof of Concept” fund has been granted to the Monash Biomedicine Discovery Institute (BDI). This award will support the key research needed to determine the effectiveness of targeting two proteins that could lead to novel, targeted treatments for triple negative breast cancer (TNBC) and other poor prognosis cancers.

Continue reading »

Hudson Researchers Receive Collaboration Grant from Pankind to Expand Targeted Screening for Pancreatic Cancer

Hudson Institute researchers Dr Daniel Croagh and Professor Brendan Jenkins have  received a share of the Australian Pancreatic Cancer Foundation’s (PanKind) 2020 Collaborative Research Grant to help accelerate the uptake of precision medicine in pancreatic cancer using endoscopic ultrasound biopsy.

Continue reading » 

Understanding how Putting the Hand Brake on Genes Could Halt Cancer

Genes in the human genome are made of DNA. Upon gene expression, a segment of DNA is copied into another molecule called RNA. When gene regulation goes wrong, diseases like cancer can occur. Therefore, knowing how enzymes — highly efficient protein nanomachines — work to switch genes on and off enables the development of new drugs and diagnostics.

Continue reading » 

The Alfred Appoints New Medical Oncology Research Manager

“The Alfred Cancer Trials unit is progressive, innovative, supportive, and driven – it’s a dynamic environment to be in, and that’s what excites me.” These are the words of Chris Brooks who was recently seconded into the role of Clinical Research Manager of Medical Oncology.

Continue reading » 

Cancer Support Referral Resource for Health Professionals

Cancer Council’s nurses provide information and support to people affected by cancer. If you have a patient or carer that needs support, please fill in the referral form and one of our cancer nurses will contact them to see how we can help. In addition, please let them know that they, or anyone affected by cancer can call our nurses on 13 11 20 (cost of a local call), Monday to Friday, 9-5pm.

New State-wide Service – MRI- guided radiation therapy at Austin Health

Victorian’s with cancer can now be referred to the Olivia Newton John Cancer Centre at Austin Health for MRI-guided radiation therapy, even if they receive cancer treatment elsewhere. This service is ideal for cancers that are difficult to treat due to anatomical changes or poor visibility. It can target a tumour clearly and avoid healthy tissue to tailor treatment to patients in real-time.

For more information and the referral form »

CRISPR Cell Service at MGMP Now 50% NCRIS Subsidised

The Monash Genome Modification Platform, in alliance with Phenomics Australia, is now offering CRISPR/Cas9 gene-editing in cells. CRISPR technology enables the production of a number of mutations not previously possible using conventional gene targeting.  We can generate knock-out, knock-in, point-mutated and tagged versions of your favourite gene in a wide variety of both human and mouse cell lines.

We offer a full service, from project design to delivery of modified clones. Use one of our proven cell lines or suggest your own to use, we are happy to discuss the possibilities. Supported by NCRIS funding, this service is available to researchers at a heavily subsidised price. For more information please contact us at

The Power of Learning Health Systems Webinar Recording Now Available

Last week almost 200 people were shown how healthcare leaders are using Learning Health Systems to inform their work. Missed the webinar? Access the recording below to hear about their benefits and challenges to drive effective and sustained healthcare improvement.

Access webinar » 
Access PowerPoint slides »

ADVANCE NOTICE – Expressions of Interest Opening Soon

Southern Melbourne Integrated Cancer Service (SMICS) Funding Program 2021-2022

SMICS has allocated funding towards a grants program for organisations providing specialist and generalist cancer services to residents of the SMICS catchment. The SMICS Grants Program 2021/22 will provide funding for quality or service improvement and redesign projects which address one or more of the Victorian Integrated Cancer Services (VICS) priorities for 2021-2022.

Health services can apply for funding for either:

  • New quality/service improvement projects (up to $100,000)
  • Service/process redesign for specific focus areas (up to $30,000)

To be notified of when EOIs open, please email

2021 Victorian Cancer Agency Funding Round - Now Open

The Victorian Cancer Agency’s research grants have been supporting innovation and excellence in cancer research since 2006, investing more than $250 million into translational research and infrastructure.

The following funding schemes are now open and will close at 2.00 pm AEST on Monday 13 September 2021:

Early Career Research Fellowships
  • Biomedical research stream
  • Non-biomedical research stream

Mid-Career Research Fellowships

  • Biomedical research stream
  • Non-biomedical research stream

Quality and Safety in Cancer Care Research Grants

  • Limited to research projects in medical oncology, malignant haematology, radiation oncology and cancer surgery intended to improve cancer survival outcomes.

More information, including guidelines, funding rules and a link to the application forms can be found at:

MRFF Clinical Trials Activity Initiative – 2021 International Clinical Trial Collaborations Grant Opportunity

Round 1: Minimum Data: 5pm ACT local time on 25 August 2021 Applications: 5pm ACT local time on 8 September 2021 
Round 2: Applications Open: 26 August 2021 Minimum Data: 5pm ACT local time on 2 February 2022 Applications: 5pm ACT local time on 16 February 2022  
Grants are a max of $12.6M 
Grants of up to 5 years.

See guidelines for details »

Tackling Financial Toxicity – Survey for health professionals

COSA invites health professionals currently working with patients with cancer to participate in a study designed to understand the knowledge, opinions and current practices of health professionals supporting patients with cancer to alleviate financial concerns.

More information »

MPCCC Precision Oncology Seminar

"Optimized 5 hydroxy-methyl seq of ctDNA as a biomarker of response in metastatic prostate cancer" 

Presented by Dr Felix Feng, Distinguished Professor of Radiation Oncology, Urology, and Medicine, University of California at San Francisco

When: Friday 27 August
Time: 1pm to 2pm
Where: online
More information/Register »

Understanding the functional consequences of every single mutation in Your Favourite Gene - Dr Alan Rubin
When: Wednesday 1 September
Time: 10am to 11.30am
Where: Online
More information/Register »

VCCC Alliance biostatistics workshop - Learn how to interpret the reporting of statistical results in clinical studies
When: Thursday 2 September
Time: 9am to 4pm
Where: Online
More information/Register »

Victorian COVID19 Cancer Network Cancer Nursing Report – the cancer costs of the pandemic
When: Tuesday 7 September
Time: 5.30pm to 6.30pm
Where: Online
More information/Register »

Incorporating consumer and community involvement into your grant applications  - MPCC consumer and community involvement lunchtime seminar series
When: Thursday 9 September
Time: 1pm to 2pm
Where: Online
More information/Register »
View upcoming seminars or watch past seminars »

VCCC Alliance Nurse-Led Research Hub Online Workshops 2021
When: 9 September to 22 October
Where: Online
More information/Register »

Good clinical practice refresher courses
This training is compulsory for employees of Monash Partners' partner organisations who plan to conduct, or are involved in, a clinical trial
When: 14 Sep, 14 Oct, 12 Nov, 9 Dec
Where: Online
More information/Register »

A transdisciplinary approach to implementation - MACH Implementation Science Seminar Series 2021
When: Wednesday 1 October
Time: 12.30pm to 1.30pm
Where: Online
More information/Register »

Advanced Communication Skills Retreat
When: 5 - 8 October
Where: Yarra Valley Lodge
More information/Register »

Victorian cancer bioinformatics symposium
When: Friday 8 October
Where: Monash University and online
More information/Register »

VICS Supportive Care Showcase – Innovative Ideas & New Realities
When: Thursday 28 October
Time: 430pm to 5.45pm
Where: Online
More information/Register »

MPCCC Precision Oncology Seminars are recorded and available to watch on YouTube at any time. Catch up on presentations from Professor Melissa Southey, Professor Tony Purcell, Associate Professor Joseph Rosenbluh and more. Watch now »

Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia  Read article »

Aspirin and Primary Prevention of Colorectal Cancer: A Still-Evolving Story  Read article »

T-ALL can evolve to oncogene independence  Read article »

Independent prognostic impact of plasma NCOA2 alterations in metastatic castration-resistant prostate cancer  Read article »

In Vitro Suppression of T Cell Proliferation Is a Conserved Function of Primary and Immortalized Human Cancer-Associated Fibroblasts  Read article »

Monash Partners Comprehensive Cancer Consortium (MPCCC) is a strategic alliance of health service and research organisations working in partnership to improve cancer outcomes through integrated, collaborative and innovative research, service improvement and clinical care programs. We are a consortium made up of clinical, research and allied partner organisations. 
Clinical partners
Alfred Health; Monash Health; Eastern Health; Peninsula Health; 
Cabrini Health; Epworth HealthCare

Research partners
Monash University; Hudson Institute of Medical Research

Allied partners
Southern Melbourne Integrated Cancer Service (SMICS); 
Monash Partners Academic Health Science Centre (Monash Partners).
If you would like to contribute to the MPCCC e-Newsletter email
Copyright © 2021 MPCCC, All rights reserved.